NCT00002986View on ClinicalTrials.gov

Chemotherapy in Treating Patients With Recurrent Malignant Glioma

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

February 28, 1997

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

carmustine

DRUG

topotecan hydrochloride

Trial Locations (2)

27710

Duke Comprehensive Cancer Center, Durham

38105-2794

Saint Jude Children's Research Hospital, Memphis

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER